Abstract
Photodynamic therapy (PDT) has been developed as an alternative modality for the management of neoplastic and nonneoplastic diseases. It is a minimally invasive treatment that involves the interaction of a non-toxic photosensitizer (PS), light and molecular oxygen to generate reactive oxygen species (ROS), resulting in the destruction of unwanted cells and tissues. Discovery and development of new PSs with optimized properties are much crucial for achieving a desirable therapeutic efficacy. This review describes the photochemical and photobiological mechanisms of PDT, and outlines the recent progress in discovery and development of natural products and their derivatives as phototherapeutic drugs. The potential limitations and future perspectives of PDT in clinical application are also presented and discussed.
Keywords: Photodynamic therapy, photosensitizer, natural product, drug discovery, anticancer, ROS.
Current Medicinal Chemistry
Title:Discovery and Development of Natural Products and their Derivatives as Photosensitizers for Photodynamic Therapy
Volume: 25 Issue: 7
Author(s): Qicai Xiao, Juan Wu, Xin Pang, Yue Jiang, Pan Wang, Albert W. Leung, Liqian Gao, Sheng Jiang and Chuanshan Xu*
Affiliation:
- School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong,China
Keywords: Photodynamic therapy, photosensitizer, natural product, drug discovery, anticancer, ROS.
Abstract: Photodynamic therapy (PDT) has been developed as an alternative modality for the management of neoplastic and nonneoplastic diseases. It is a minimally invasive treatment that involves the interaction of a non-toxic photosensitizer (PS), light and molecular oxygen to generate reactive oxygen species (ROS), resulting in the destruction of unwanted cells and tissues. Discovery and development of new PSs with optimized properties are much crucial for achieving a desirable therapeutic efficacy. This review describes the photochemical and photobiological mechanisms of PDT, and outlines the recent progress in discovery and development of natural products and their derivatives as phototherapeutic drugs. The potential limitations and future perspectives of PDT in clinical application are also presented and discussed.
Export Options
About this article
Cite this article as:
Xiao Qicai, Wu Juan, Pang Xin , Jiang Yue, Wang Pan , Leung W. Albert , Gao Liqian, Jiang Sheng and Xu Chuanshan*, Discovery and Development of Natural Products and their Derivatives as Photosensitizers for Photodynamic Therapy, Current Medicinal Chemistry 2018; 25 (7) . https://dx.doi.org/10.2174/0929867324666170823143137
DOI https://dx.doi.org/10.2174/0929867324666170823143137 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuregulin1 as Novel Therapy for Heart Failure
Current Pharmaceutical Design Intracranial Aneurysms; In Need of Early Diagnostic and Treatment Using Bio- and Nanotechnology
Current Medicinal Chemistry Cardio-Hepatic Metabolic Derangements and Valproic Acid
Current Clinical Pharmacology Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Current Drug Metabolism Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma
Mini-Reviews in Medicinal Chemistry Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage Score For Predicting Outcome
Current Neurovascular Research p53 Gene Family: Structural, Functional and Evolutionary Features
Current Genomics Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Is Glyburide Safe in Pregnancy?
Current Pharmaceutical Biotechnology Regulation of Angiogenesis by the Small Heat Shock Protein αB-Crystallin
Current Angiogenesis (Discontinued) Nutritional and Pharmacological Management of Childhood Epilepsy: Ketogenic Diets and Common AEDs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease
Current Pharmaceutical Design Subject Index to Volume 4
Current Genomics Medullary Thyroid Cancer: A Promising Model for Targeted Therapy
Current Molecular Medicine Pharmacological Applications of Antioxidants: Lights and Shadows
Current Drug Targets bmp3 is Required for Integrity of Blood Brain Barrier by Promoting Pericyte Coverage in Zebrafish Embryos
Current Molecular Medicine